Re-illness with a new coronavirus infection in a patient with myocardial infarction: a clinical case
https://doi.org/10.51793/OS.2022.25.3.007
Abstract
The high-risk groups for the development of severe forms of a new coronavirus infection include elderly people with concomitant pathology of the respiratory system, cardiovascular system, etc. The report describes a clinical case of recurrent disease with a new coronavirus infection (COVID-19), in a patient aged 74 years, which occurred with lung damage on the background of myocardial infarction. The repeated disease developed in the presence of specific IgG class antibodies in the amount of 3,9 units and proceeded with lung damage (up to 20%) in the form of bilateral polysegmental pneumonia with subpleural changes of the «frosted glass» type, which is typical for patients with COVID-19 complicated by pneumonia. According to the assessment protocol (NEWS) – the patient's condition, at the beginning of the disease and in the following days, of moderate severity. The disease proceeded without respiratory failure, with an oxygen saturation of 96-97%. The etiology of the disease was confirmed in the laboratory by PCR of a pharyngeal smear on SARS-CoV-2 RNA and by the ELISA method. The patient completed the course of treatment with positive dynamics. He was discharged for the outpatient stage of treatment on the 12th day from the onset of the disease in a satisfactory condition with a final diagnosis: COVID-19 coronavirus infection, the virus was identified as a moderate form. Community-acquired bilateral polysegmental pneumonia. Ischemic heart disease, Q-forming myocardial infarction of the lower wall of the region from 21.01.2021 Gravity class according to Killip I. Stenosing atherosclerosis of the coronary arteries. Arterial hypertension is 3 art.risk. Dyslipidemia, Chronic heart failure 1 with a preserved ejection fraction of 58%. Hypertensive crisis from 21.01.2021 We hope that the article will be of interest to doctors of practical healthcare in terms of medical education on the problem of coronavirus infection.
About the Authors
G. A. Kharchenko
Federal State Budgetary Educational Institution of Higher Education Astrakhan State Medical University of the Ministry of Health of the Russian Federation
Russian Federation
Russian Federation
Gennady A. Kharchenko, Dr. of Sci. (Med.), Professor, Head of the
Department of Children's Infections
121 Bakinskaya str., Astrakhan, 414000
O. G. Kimirilova
Federal State Budgetary Educational Institution of Higher Education Astrakhan State Medical University of the Ministry of Health of the Russian Federation
Russian Federation
Russian Federation
Olga G. Kimirilova, MD, Associate Professor of the Department of Pediatric Infections
121 Bakinskaya str., Astrakhan, 414000
References
1. Evsyutina Yu. V. Community-hospital pneumonia, briefly about the main thing. What is important to know the practitioner doctor. Material Kongressa «CHelovek i lekarstvo» i 3-go Sammita pul'monologov // Lechashchij Vrach. 2019; 11: 56-59. (In Russ.)
2. Zajcev A. A. Complete-headed pneumonia: the possibilities of diagnosis, treatment and vaccine-philatics under conditions of Pandemia COVID-19 // Prakticheskaya pul'monologiya. 2020; 1: 14-20. (In Russ.)
3. Rachina S. A., Sinopal'nikov A. I. Clinical recommendations for communityfriendly pneumonia in adults: What is waiting for us in 2019 // Prakticheskaya pul'monologiya. 2018; 3: 8-13. (In Russ.)
4. Federal clinical recommendations. Complete pneumonia. M.: MZ RF, 2018. (In Russ.)
5. Shah R. D., Wunderink R. G. Viral Pneumonia and Acute Respiratory Distress Syndrome // Clin Chest Med. 2017; 38: 113-125.
6. Nikiforov V. V., Supanova T. G., CHernobrovkina T. Ya., Yankovskaya Ya. D., Burov S. V. New coronavirus infection (COVID-19): Clinical and epidemiological aspects // Arhiv vnutrennej mediciny. 2020; 2: 87-94. (In Russ.)
7. Romanov B. K. Koronavirusnaya infekciya COVID-19 [Coronavirus infection COVID-19] // Bezopasnost' i risk farmakoterapii. 2020; 8 (1): 3-6 (In Russ.)
8. Rumyancev A. G. Coronavirus infection COVID-19. Scientific challenges and possible ways of treating and preventing the disease // Ross. Zhurnal detskoj gematologii i onkologii. 2020; 7 (3): 47-53. (In Russ.)
9. Starshinova A. A., Kushnareva E. A., Malkova A. M., Dovgalyuk I. F., Kudlaj D. A. Novaya koronavirusnaya infekciya: osobennosti klinicheskogo techeniya, vozmozhnosti diagnostiki, lecheniya i profilaktiki u vzroslyh i detej [New Coronavirus infection: Features of the clinical course, the possibility of diagnosis, treatment and prevention in adults and children] // Voprosy sovremennoj pediatrii. 2020; 19 (2): 123-131. (In Russ.)
10. Vremennye metodicheskie rekomendacii. Profilaktika, diagnostika i lechenie novoj koronavirusnoj infekcii COVID-19. Versiya 11 (07.05.2021 [Temporary guidelines. Prevention, diagnosis and treatment of a new coronavirus infection COVID-19. Version 11 (07/05/2021)] / Otvetstvennayaorganizaciya: Federal'noe gosudarstvennoe avtonomnoe obrazovatel'noe uchrezhdenie vysshego obrazovaniya «Rossijskij nacional'nyj issledovatel'skij medicinskij universitet imeni N. I. Pirogova» Ministerstva zdravoohraneniya Rossijskoj Federacii. (InRuss.) http://brat-med.ru/Vremennye-metodicheskierekomenda-COVID-19-Versiya-11-07-05-2021.
11. Jain S., Self W. H., Wunderink R. G. et al. Community-Acquired Pneumonia Requiring Hospitalization // N Engl J. Med. 2015; 373: 2382.
12. Wu X., Wang Q., Wang M. S. et al. Incidence of respiratory viral infections detected by PCR and real-time PCR in adult patients with communityacquired pneumonia: a meta-analysis // Respiration. 2015; 89: 343-352.
13. Piralla A., Rovida F., Girello A. et al. Frequency of respiratory virus infections and next-generation analysis of influenza A/H1N1pdm09 dynamics in the lower respiratory tract of patients admitted to the ICU // PloS One. 2017; 12: e0178926.
14. Shah R. D., Wunderink R. G. Viral Pneumonia and Acute Respiratory Distress Syndrome // Clin Chest Med. 2017; 38: 113-125.
Review
For citations:
Kharchenko G.A., Kimirilova O.G. Re-illness with a new coronavirus infection in a patient with myocardial infarction: a clinical case. Lechaschi Vrach. 2022;(3):44-48. (In Russ.) https://doi.org/10.51793/OS.2022.25.3.007
Views:
726
JATS XML
Email this article 
